ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. (NYSE; PFE) and Shionogi Limited as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

UPDATE: Pfizer (PFE) Tops Q2 EPS by 5c, Revenues Miss; Lowers FY19 EPS/Revenue GuidanceJuly 29, 2019 6:51 AM ViiV Healthcare Submits Regulatory Application to European Medicines Agency for Investigational Cabotegravir to Be Used in Combination With Rilpivirine as the First Monthly, Injectable Treatment for HJuly 29, 2019 2:06 AM